Skip to main content
. 2024 Aug 29;17:3217–3226. doi: 10.2147/DMSO.S472174

Figure 3.

Figure 3

Effects of IDegLira early conversion on weight (A), insulin dosage (B), HbA1c (C), and fasting C-peptide (D) in T2DM patients. p values: Pre-IDegLira group vs IDegLira-3 months group.